Trials / Completed
CompletedNCT03808142
PROmyBETAappGame: a Study to Learn More About the Medication Usage & Patient Reported Outcomes Via the myBETAapp and to Find Out More About the Usage of Game Principles and Game Design Elements (Gamification) in Medical Care of Patients With Multiple Sclerosis Treated With Betaferon
PROmyBETAappGame: Ascertaining Medication Usage & Patient Reported Outcomes Via the myBETAapp and Exploring Gamification in Patients With Multiple Sclerosis Treated With Betaferon
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 79 (actual)
- Sponsor
- Bayer · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this study researchers wanted to learn more about the medication usage behavior among multiple sclerosis (MS) patients treated with Betaferon using the myBETAapp which includes the elements to what extent * taking medication matched the presciber´s recommendation (adherence, compliance), * treatment for the prescribed duration (persistence) was continued and * injections were missed. Among MS patients treated with Betaferon using the myBETAapp the study also collected information on the health-related quality of life, treatment satisfaction and satisfaction with treatment support.
Detailed description
The PROmyBETAappGame study was a mixed prospective and retrospective, non-interventional, observational cohort study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | myBETAapp | Patients choosing to use the myBETAapp were required to insert the Mixject number from their prescribed Betaferon box, which serves as an opening key for the app. Obtaining a new Betaferon box and obtaining a new Mixject number was not interfere with the process of continuously allocating data to a single patient; each patient had a unique personal identifier in the database. All data recorded in the myBETAapp including demographic and injection-related data were stored in the database once the mobile device was connected to the internet. |
| OTHER | PEAK | Peak is an application that aims at helping its users to challenge their brains and keep them sharp. |
| DRUG | Betaferon, BAY86-5046 | Injection |
| DEVICE | BETACONNECT | BETACONNECT automatically records and stores injection-related details including injection time, speed, and depth upon every injection. |
Timeline
- Start date
- 2019-02-20
- Primary completion
- 2020-04-20
- Completion
- 2020-09-02
- First posted
- 2019-01-17
- Last updated
- 2021-08-25
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03808142. Inclusion in this directory is not an endorsement.